Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of a test
formulation of oxcarbazepine tablets and Trileptal® tablets administered as a 1 x 600 mg dose
under fed conditions.